Image pharmaphorum Editor Digital Frontiers Health 2024: Day One Welcome to our live coverage of Frontiers Health 2024 - Day One! Digital Frontiers Health 2024 Live Coverage Frontiers Health is back, bringing together healthcare innovators from around the world to exchange insights and discuss the hottest healthcare trends News Remembering Paul Bannister, dear friend and finance manager On Sunday 28th July, pharmaphorum lost a much-beloved member of the family. Digital Reuters Pharma Europe 2024 – Day Two And we’re live on site all day again on Day Two of Reuters Pharma Europe 2024 in Barcelona. Load more results
Digital Frontiers Health 2024: Day One Welcome to our live coverage of Frontiers Health 2024 - Day One!
Digital Frontiers Health 2024 Live Coverage Frontiers Health is back, bringing together healthcare innovators from around the world to exchange insights and discuss the hottest healthcare trends
News Remembering Paul Bannister, dear friend and finance manager On Sunday 28th July, pharmaphorum lost a much-beloved member of the family.
Digital Reuters Pharma Europe 2024 – Day Two And we’re live on site all day again on Day Two of Reuters Pharma Europe 2024 in Barcelona.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.